Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
11.30
-0.40 (-3.42%)
At close: Jul 10, 2026, 4:00 PM EDT
11.13
-0.18 (-1.55%)
After-hours: Jul 10, 2026, 4:10 PM EDT
Burning Rock Biotech Market Cap
Burning Rock Biotech has a market cap or net worth of $119.17 million as of July 10, 2026. Its market cap has increased by 226.51% in one year.
Market Cap
119.17M
Enterprise Value
61.89M
1-Year Change
226.51%
Ranking
Category
Stock Price
$11.30
Market Cap Chart
Since June 12, 2020, Burning Rock Biotech's market cap has decreased from $2.51B to $119.17M, a decrease of -95.25%. That is a compound annual growth rate of -39.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 119.17M | -45.07% |
| Dec 31, 2025 | 216.95M | 213.30% |
| Dec 31, 2024 | 69.25M | -29.38% |
| Dec 29, 2023 | 98.06M | -58.57% |
| Dec 30, 2022 | 236.67M | -76.25% |
| Dec 31, 2021 | 996.35M | -58.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CareDx | 1.47B |
| OPKO Health | 1.02B |
| Castle Biosciences | 719.43M |
| Fulgent Genetics | 583.63M |
| Myriad Genetics | 550.63M |
| Biodesix | 221.82M |
| Insight Molecular Diagnostics | 164.03M |
| Exagen | 107.51M |